ClassID:

170813

G01N2800/105 - CPC Classification

Classification description:

Detection or diagnosis of diseases; Musculoskeletal or connective tissue disorders Osteoarthritis, e.g. cartilage alteration, hypertrophy of bone

Recent Application in this class:
#1
20260072016
2026-03-12

COMPOSITIONS, DEVICES, AND METHODS OF OSTEOARTHRITIS SENSITIVITY TESTING

#2
20260023084
2026-01-22

COMP PEPTIDE AND ANTIBODIES THERETO FOR DIAGNOSING OSTEOARTHRITIS

#3
20250285762
2025-09-11

METHOD FOR DETERMINING WHETHER A SUBJECT IS AT RISK OF DEVELOPING A MUSCULOSKELETAL AND/OR CONNECTIVE TISSUE DISEASE

#4
20250271450
2025-08-28

BIGLYCAN PEPTIDE AND ANTIBODIES

#5
20250258175
2025-08-14

COMPOSITIONS AND METHODS FOR DIAGNOSING AND ASSESSING RHEUMATOID ARTHRITIS

#6
20250250360
2025-08-07

ANTI-SULFATASE-RELATED ANTIGEN SPECIFIC ANTIBODY, DETECTION KIT COMPRISING ANTI-SULFATASE-RELATED ANTIGEN SPECIFIC ANTIBODY, AND METHOD FOR DETECTING OSTEOARTHRITIS AND PROGNOSTIC MONITORING OF OSTEOARTHRITIS PROGRESSION BY USING ANTI-SULFATASE-RELATED ANTIGEN SPECIFIC ANTIBODY

#7
20250138026
2025-05-01

METHOD FOR DIAGNOSING COLLAGEN DEGRADATION ASSOCIATED DISEASE

#8
20250093349
2025-03-20

Antigens Derived from Citrullinated 14-3-3 and Uses Thereof in the Diagnosis of Rheumatoid Arthritis

#9
20250012784
2025-01-09

METHODS OF DIAGNOSING AND TREATING OSTEOARTHRITIS

#10
20240415932
2024-12-19

Systems and Methods for Angiogenic Treatment in Wound Healing

#11
20240310383
2024-09-19

Proteomic Risk Score For Osteoarthritis (OA)

#12
20240075053
2024-03-07

ROR2 INHIBITORS AND USE THEREOF IN TREATING AND/OR PREVENTING CARTILAGE LOSS

#13
20230399397
2023-12-14

ANTI-OSCAR ANTIBODY FOR PREVENTING OR TREATING OSTEOARTHRITIS

#14
20230358730
2023-11-09

SIMULATED SYNOVIAL FLUIDS FOR MODELING DEGENERATIVE JOINT DISEASES AND SCREENING FOR THERAPEUTICS FOR SAME

#15
20230251271
2023-08-10

METABOLIC BIOMARKERS FOR PREDICTING RESPONSIVENESS TO FGF-18 COMPOUND

#16
20230110824
2023-04-13

FLUORESCENT PROBES FOR DETECTION OF CALCIFICATIONS

#17
20230047431
2023-02-16

Composition for treating or diagnosing osteoarthritis targeting ACVR2B

#18
20230000842
2023-01-05

METHODS OF TREATING CARTILAGE DISORDERS THROUGH INHIBITION OF CLK AND DYRK

#19
20220390466
2022-12-08

BIOMARKERS OF EARLY OSTEOARTHRITIS

#20
20220196680
2022-06-23

OSTEOMODULIN AND OSTEOMODULIN FRAGMENTS AS BIOMARKERS FOR OSTEOARTHRITIS AND USE THEREOF

#21
20220146528
2022-05-12

Collagen Type X Alpha-1 Assay

#22
20220137048
2022-05-05

PRE-SURGICAL DIAGNOSTIC TOOL USING BIOMARKERS TO EVALUATE THE RISK FACTORS OF POST SURGICAL COMPLICATIONS

#23
20220091136
2022-03-24

Early detection marker for degenerative osteoarthritis with TRIM24-RIP3 axis

#24
20210405047
2021-12-30

ANTI-CARBAMYLATED PROTEIN ANTIBODIES AND THE RISK FOR ARTHRITIS

#25
20210231681
2021-07-29

Metabolic biomarkers for predicting responsiveness to FGF-18 compound

#26
20210033605
2021-02-04

Lateral flow immunoassay strip device

#27
20200392222
2020-12-17

IL-18 binding protein (IL-18BP) in inflammatory diseases

#28
20200360417
2020-11-19

ROR2 inhibitors and use thereof in treating and/or preventing cartilage loss

#29
20200264177
2020-08-20

Compositions and methods for diagnosing and assessing rheumatoid arthritis

#30
20200237873
2020-07-30

Systems and methods for angiogenic treatment in wound healing

#31
20200232034
2020-07-23

Methods of detecting osteoarthritis and predicting progression thereof

#32
20200132699
2020-04-30

Methods for the diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions in canines

#33
20200110087
2020-04-09

ANTI-CARBAMYLATED PROTEIN ANTIBODIES AND THE RISK FOR ARTHRITIS

#34
20200079830
2020-03-12

Peptides and compositions for treatment of joint damage

#35
20190317091
2019-10-17

Method of early diagnosis of immune-mediated inflammatory disease

#36
20190310249
2019-10-10

Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis

#37
20190185530
2019-06-20

Complex-specific standardization of immunological methods for the quantification of S100A12

#38
20190161527
2019-05-30

Peptides and compositions for treatment of joint damage

#39
20190137514
2019-05-09

COMPEPTIDE AND ANTIBODIES THERETO FOR DIAGNOSING OSTEOARTHRITIS

#40
20190101533
2019-04-04

ANIMAL MODEL FOR STUDYING ZCCHC6 IN BONE DISEASE AND DEVELOPMENT

#41
20190064186
2019-02-28

Biomarkers for Cell Therapy

#42
20190056408
2019-02-21

COMPOSITIONS, DEVICES, AND METHODS OF OSTEOARTHRITIS SENSITIVITY TESTING

#43
20190011459
2019-01-10

Osteomodulin and osteomodulin fragments as biomarkers for osteoarthritis and use thereof

#44
20190008885
2019-01-10

MiRNA biomarkers for cartilage degeneration

#45
20190004044
2019-01-03

Anti-carbamylated protein antibodies and the risk for arthritis

#46
20180296706
2018-10-18

Micro- and nano-device for cartilage injury detection and treatment

#47
20180224463
2018-08-09

MEl'hods and means for diagnosing spondylarthritis using autoantibody markers

#48
20180194823
2018-07-12

Peptides and compositions for treatment of joint damage

#49
20180156816
2018-06-07

Immunoassays of s-adenosylmethionine and methylation index in personalized medicine and health evaluation

#50
20170327552
2017-11-16

Peptides and compositions for treatment of joint damage

#51
20170211070
2017-07-27

Prophylactic agent and therapeutic agent for fibrodysplasia ossificans progressiva

#52
20170129948
2017-05-11

Antibody

#53
20170105971
2017-04-20

METHODS AND COMPOUNDS FOR THE TREATMENT OF BONE LOSS AND/OR PAIN

#54
20170097360
2017-04-06

Methods for treating inflammatory and other diseases and the use of biomarkers as predictors of clinical sensitivity to treatment with apremilast

#55
20170030925
2017-02-02

Biomarkers of osteoarthritis

#56
20170016913
2017-01-19

METHODS AND SYSTEM FOR DETERMINING THE DISEASE STATUS OF A SUBJECT

#57
20160376337
2016-12-29

Peptides and compositions for treatment of joint damage

#58
20160345941
2016-12-01

Magnetic apparatus and methods of use

#59
20160299155
2016-10-13

Methods for diagnosing osteoarthritis

#60
20160245825
2016-08-25

Biomarkers for Cell Therapy

#61
20160244491
2016-08-25

Peptides and compositions for treatment of joint damage

#62
20160223570
2016-08-04

METHODS AND KITS FOR DIAGNOSING AND/OR PROGNOSING OSTEOARTHRITIS

#63
20160215048
2016-07-28

IL-18 binding protein (IL-18BP) in inflammatory diseases

#64
20160208266
2016-07-21

Methods and means for treatment of osteoarthritis

#65
20160123993
2016-05-05

Collagen Type X Alpha-1 Assay

#66
20160055647
2016-02-25

Medical image processing apparatus and method for medical image processing

#67
20160041154
2016-02-11

Immunoassays of S-adenosylmethionine and methylation index in personalized medicine and health evaluation

#68
20160030439
2016-02-04

Methods for the treatment of autoimmune diseases

#69
20160000938
2016-01-07

REAGENT FOR DIAGNOSIS OF OSTEOARTHRITIS COMPRISING PEPTIDE PROBE OF APOPEP-1

#70
20150369819
2015-12-24

TMEM120A ion channel modulator

#71
20150301065
2015-10-22

Determining pathological cartilage turnover

#72
20150204888
2015-07-23

Quantifying local inflammatory activity and its use to predict disease progression and tailor treatments

#73
20150164994
2015-06-18

Systems and methods for angiogenic treatment in wound healing

#74
20150153362
2015-06-04

METHODS FOR DIAGNOSING OSTEOARTHRITIS

#75
20150141332
2015-05-21

METHODS FOR DIAGNOSING OSTEOARTHRITIS

#76
20150072364
2015-03-12

Methods and kits for diagnosing osteoarthritis and predicting progression

#77
20150037823
2015-02-05

Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof

#78
20140329252
2014-11-06

METHODS AND KITS FOR DIAGNOSING AND/OR PROGNOSING OSTEOARTHRITIS

#79
20140255957
2014-09-11

Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis

#80
20140162297
2014-06-12

Anti-carbamylated protein antibodies and the risk for arthritis

#81
20140155499
2014-06-05

Biomarkers of osteoarthritis

#82
20130309694
2013-11-21

Hybridoma cell line for producing antibody for type II collagen

#83
20130203088
2013-08-08

Methods and means for diagnosing spondylarthritis using autoantibody markers

#84
20130202533
2013-08-08

Methods for modulating skeletal remodeling and patterning by modulating SHN2 activity, SHN3 activity, or SHN2 and SHN3 activity in combination

#85
20130041024
2013-02-14

Methods for the diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions in canines

#86
20130017965
2013-01-17

OSTEOARTHRITIS BIOMARKERS AND USES THEREOF

#87
20130004957
2013-01-03

Prevention and treatment of osteoarthritis

#88
20120316114
2012-12-13

Variants of C-type natriuretic peptide

#89
20120252870
2012-10-04

Indian Hedgehog (Ihh) as a Marker to Predict Osteoarthritis (OA) and Methods for the Prevention and Treatment of OA

#90
20120190727
2012-07-26

Method and means for treatment of osteoarthritis

#91
20120190042
2012-07-26

PROTEIN BIOMARKERS AND THERAPEUTIC TARGETS FOR OSTEOARTHRITIS

#92
20120122117
2012-05-17

Secreted phospholipase A2 biomarkers for arthritis

#93
20120065094
2012-03-15

Methods and kits for diagnosing osteoarthritis and predicting progression

#94
20120028369
2012-02-02

Quantifying local inflammatory activity and its use to predict disease progression and tailor treatments

#95
20120027766
2012-02-02

Methods and means for treatment of osteoarthritis

#96
20120015992
2012-01-19

Naphthalene-based inhibitors of anti-apoptotic proteins

#97
20120004311
2012-01-05

Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)

#98
20110306152
2011-12-15

System and Method for Determining Concentration of a Predetermined Osteoarthritis Biomarker in a Urine Sample

#99
20110281285
2011-11-17

Assay for Detecting Cathepsin K Activty in Bone, Cartilage and/or Soft Tissue

#100
20110256639
2011-10-20

ASSESSMENT OF PROTEIN DEGRADATION BY MEASUREMENT OF ISOMERISED NEO-EPITOPE CONTAINING FRAGMENTS

#101
20110244483
2011-10-06

ASSESSMENT OF PROTEIN DEGRADATION BY MEASUREMENT OF COLLAGEN FRAGMENTS

#102
20110244482
2011-10-06

ASSESSMENT OF SUBCHONDRAL BONE REMODELLING BY MEASURING CATHEPSIN K FRAGMENTS OF COLLAGEN TYPE II

#103
20110218116
2011-09-08

BIOMARKERS OF OSTEOARTHRITIS

#104
20110184251
2011-07-28

BONE MINERAL DENSITY RATIOS AS A PREDICTOR OF OSTEOARTHRITIS

#105
20110159607
2011-06-30

BIOMARKER FOR OSTEOARTHRITIS AND/OR OTHER AGEING-RELATED DISEASES, AND USE THEREOF

#106
20110159514
2011-06-30

Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof

#107
20110151492
2011-06-23

Method of detecting articular cartilage degeneration or damage

#108
20110076708
2011-03-31

Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions

#109
20110065899
2011-03-17

Antibody against RGD in amino acid sequence of extracellular matrix protein and production method and use of the same

#110
20110065102
2011-03-17

OSTEOARTHRITIS-SENSITIVE GENE

#111
20100330036
2010-12-30

MARKERS OF MATRIX GENE EXPRESSION AND CELLULAR DIFFERENTIATION IN CHONDROCYTES

#112
20100323908
2010-12-23

Methods and compositions for diagnosing osteoarthritis in a feline

#113
20100323455
2010-12-23

Diagnostic assay for human matrix GLA-protein and its use as a biomarker

#114
20100297021
2010-11-25

Variants of C-type natriuretic peptide

#115
20100292154
2010-11-18

PROTEIN PROFILE FOR OSTEOARTHRITIS

#116
20100267781
2010-10-21

Naphthalene-based inhibitors of anti-apoptotic proteins

#117
20100239501
2010-09-23

GENE SENSITIVE TO BONE/JOINT DISEASE AND USE THEREOF

#118
20100221767
2010-09-02

DIAGNOSTIC METHOD AND PROGNOSTIC TOOL FOR OSTEOARTHRITIS

#119
20100196402
2010-08-05

Method for Predicting the Response of a Patient to Treatment with an Anti-TNF Alpha Antibody

#120
20100150838
2010-06-17

METHODS FOR EVALUATING OSTEOARTHRITIS RISK

#121
20100143916
2010-06-10

Osteoarthritis biomarkers and uses thereof

#122
20100129378
2010-05-27

Treatment and diagnosis of abnormal bone density with an inhibitor of the glypican-sclerostin interaction

#123
20100087514
2010-04-08

METHOD AND MEANS FOR TREATMENT OF OSTEOARTHRITIS

#124
20100028882
2010-02-04

METHODS FOR DIAGNOSING OSTEOARTHRITIS

#125
20090311243
2009-12-17

Methods for Identifying FZD8 Modulators and the Use of such Modulators for Treating Osteoarthritis

#126
20090305980
2009-12-10

Methods and Compositions Related to TR4

#127
20090239804
2009-09-24

Prevention and treatment of osteoarthritis

#128
20090226552
2009-09-10

AGENTS AND METHODS FOR DIAGNOSING OSTEOARTHRITIS

#129
20090170720
2009-07-02

Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases

#130
20090149332
2009-06-11

METHODS FOR DETERMINING THE ACTIVITY OF ADAM-TS PROTEASES USING THIOPEPTOLIDES

#131
20090117107
2009-05-07

Molecular targets and compounds, and methods to identify the same, useful in the treatment of bone and joint degenerative diseases

#132
20090076481
2009-03-19

Therapeutic angiogenesis for treatment of the spine

#133
20090075921
2009-03-19

Bone/joint disease sensitivity gene and use thereof

#134
20090068656
2009-03-12

Methods of diagnosing osteoarthritis

#135
20090012053
2009-01-08

Use of LXR agonists for the treatment of osteoarthritis

#136
20090012026
2009-01-08

Association Between the Tdoa Gene and Osteoarthritis

#137
20080274487
2008-11-06

Use of Serum/Glucocorticoid-Regulated Kinase

#138
20080261910
2008-10-23

Diagnostic Methods Based on Polymorphisms of Glucosyltransferase-Like Protein

#139
20080241945
2008-10-02

Peptide for differentiating osteoarthritis from rheumatoid arthritis and non-disease conditions

#140
20080241851
2008-10-02

Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions

#141
20080213807
2008-09-04

Methods of Using Bone Morphogenic Proteins as Biomarkers for Determining Cartilage Degeneration and Aging

#142
20080173805
2008-07-24

Methods and apparatus for multi dimension fluorescence spectrum measurement downhole

#143
20080108145
2008-05-08

GENES ASSOCIATED WITH OSTEOARTHRITIS

#144
20080069811
2008-03-20

Methods for inhibiting osteoclastic bone resorption and bone loss comprising administration of an anti-FSH or anti-FSHR antibody

#145
20080026362
2008-01-31

Three-dimensional culture containing human articular chondrocytes with induced terminal differentiation changes and preparation process and uses of the same

#146
20080009439
2008-01-10

Compositions and Methods of Use for a Fibroblast Growth Factor

#147
20070298416
2007-12-27

Genes associated with canine osteoarthritis and related methods and compositions

#148
20070292892
2007-12-20

Uncoupled collagen synthesis and degradation assays

#149
20070292881
2007-12-20

Methods of diagnosing and treating rheumatoid arthritis and osteoarthritis

#150
20070248605
2007-10-25

Fibroblast Growth Factor Receptors 1,2,3, and 4 as Targets for Therapeutic Intervention

#151
20070243186
2007-10-18

ISLR gene and its association with osteoarthritis and other bone and cartilage disorders, expression products derived therefrom, and uses thereof

#152
20070225206
2007-09-27

Methods for evaluating osteoarthritis risk

#153
20070207480
2007-09-06

Method of diagnosing osteoarthritis

#154
20070142273
2007-06-21

Methods and compositions targeting tyrosine kinases for the diagnosis and treatment of osteoarthritis

#155
20070099246
2007-05-03

Antibodies, assays and kits to quantitate cartilage destruction

#156
20070038386
2007-02-15

Computer systems and methods for inferring casuality from cellular constituent abundance data

#157
20070021496
2007-01-25

Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass

#158
20070015178
2007-01-18

Methods of using bone morphogenic proteins as biomarkers for determining cartilage degeneration and aging

#159
20070004658
2007-01-04

Method and means for treatment of osteoarthritis

#160
20060241869
2006-10-26

Computer systems and methods for inferring causality from cellullar constituent abundance data

#161
20060147378
2006-07-06

Azulene dimer-quenched, near-infrared fluorescent probes

#162
20060127953
2006-06-15

Method of diagnosing osteolysis

#163
20060094061
2006-05-04

Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases

#164
20060034846
2006-02-16

Use of TF antagonists

#165
20050221383
2005-10-06

Osteoarthritis biomarkers and uses thereof

#166
20050089881
2005-04-28

Superficial zone protein-binding molecules and uses thereof

#167
20050084841
2005-04-21

Isle gene and its association with osteoarthritis and other bone and cartilage disorders expression products derived therefrom and uses thereof

#168
20050074744
2005-04-07

Assays for evaluating anti-osteoarthritic activity

#169
20050065325
2005-03-24

Assay for YKL-40 as a marker for degradation of mammalian connective tissue matrices